TRIPLE NEGATIVE BREAST CANCER (TNBC)

Clinical trials for TRIPLE NEGATIVE BREAST CANCER (TNBC) explained in plain language.

Never miss a new study

Get alerted when new TRIPLE NEGATIVE BREAST CANCER (TNBC) trials appear

Sign up with your email to follow new studies for TRIPLE NEGATIVE BREAST CANCER (TNBC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 21 Not yet recruiting 7 Not yet finished but already full! 6 Terminated 1

Radioactive bullet targets advanced cancers in early trial

Disease control Terminated

This early-stage study tested a new radioactive drug designed to target and destroy advanced solid tumors. It involved 78 patients with various cancers who had run out of standard treatment options. The main goals were to check the treatment's safety, find the right dose, and see…

Matched conditions: TRIPLE NEGATIVE BREAST CANCER (TNBC)

Phase: PHASE1 • Sponsor: Fusion Pharmaceuticals Inc. • Aim: Disease control

Last updated Mar 30, 2026 14:29 UTC

TRIPLE NEGATIVE BREAST CANCER (TNBC)

Get alerted when new TRIPLE NEGATIVE BREAST CANCER (TNBC) trials appear

Radioactive bullet targets advanced cancers in early trial